Top 5 HealthLeaders Exchange topics shaping revenue cycle.

Top 5 HealthLeaders Exchange topics shaping revenue cycle.

At the October HealthLeaders CEO + CFO Exchange, health system executives kept coming back to the same challenge: there are plenty of worthwhile priorities, but only so much capacity to execute them well.

When every investment has a strong case behind it, the harder decision is where to focus and what to put on hold.

Revenue cycle tends to make the financial impact of these choices easy to see. Priorities that are poorly sequenced or under-resourced slow billing, increase rework, and delay reimbursement, while strong execution results in improved First-Pass Performance and more predictable financial performance.

Here are the top five takeaways from the event on where execution makes or breaks those results:

‍

1. Strategic priorities have to survive the execution test. | Execution Determines Value

‍A projected return is only as strong as the plan for delivering it.

Before saying yes to a new initiative, CEOs and CFOs should know what it will ask of teams, who can fix the underlying workflow, and whether the rollout will disrupt the work that keeps cash moving.

Take a new prior authorization tool, for example. Spotting payer requirements faster doesn't strengthen reimbursement if missing documentation and unresolved exceptions still land back in manual queues. A tool that finds problems but fixes none is just a messenger. An executable plan ties prior authorization to scheduling, documentation readiness, escalation ownership, and denial feedback, so the investment prevents authorization delays instead of reporting them.

Executives at the Exchange shared four conditions that separate an executable revenue cycle investment from another layer of work:

• The financial outcome is clearly defined in cash, reimbursement, margin, or cost-to-collect.
• The workflow owner can change the process where defects begin.
• Every team the workflow touches has agreed to the handoffs the change affects.
• Governance can prove the change removes rework after launch.

‍

2. Portfolio discipline protects workforce capacity and cash. | Priorities Protect Capacity

No one votes for an overloaded portfolio. It happens one reasonable yes at a time. 

Countless leaders at the Exchange described teams carrying more active work than they could execute. The same revenue cycle leaders, analysts, and IT resources support every initiative, so each new project slows the rest and pushes the return later than the business case promised.

A portfolio review makes that overlap visible. It lines up each initiative's expected cash and margin improvement against the demand it places on shared teams, workflow dependencies, and time to value. The result shows where capacity is already spoken for and which initiatives return the most for the capacity they use.

Capacity is the one budget line nobody can approve into existence. A good idea that starts a little later, with a team ready to carry it, can still deliver sooner than one launched into a team with no room.

‍

3. Revenue cycle investments are often fully funded but partially staffed. | Workforce Capacity Protects Cash

Approving the investment is the easy part. Finding the capacity to carry it through is harder. 

Executives at the Exchange were clear about the pressure on operational teams: constant reprioritization is driving burnout and leaving less capacity for new initiatives. The same teams keeping cash moving are often asked to learn new workflows, support the rollout, and handle whatever the technology cannot resolve.

The pressure adds up. When teams have to balance daily operations with implementation work, burnout rises, queues grow, and the expected return takes longer to show up. The investment can still succeed, but the organization pays more for the transition than leaders anticipated.

A stronger revenue cycle operating model plans for the workload created by the change. Deeper specialist coverage gives key employees room to focus and keeps work moving when volumes rise, payer requirements shift, or experienced team members are unavailable.

The takeaway for CEOs and CFOs is simple: funding the technology is only part of the investment. The larger decision is whether the organization has enough capacity to protect current performance while building what comes next. Funding the people and operating model behind the change reduces burnout, preserves cash during the transition, and creates the execution capacity needed to support future growth.

‍

4. AI should create value, not another queue. | AI Must Move Work

Artificial Intelligence (AI) creates financial value when it improves the economics of getting paid. Leaders should see faster claim readiness, fewer preventable denials, lower cost-to-collect, or more productive use of skilled teams. If AI identifies more issues but leaves the same manual work behind, it has improved visibility without improving financial performance.

CFOs can compare time to bill, denial rates, exception aging, manual touch volume, and labor cost before and after implementation. The value comes from strengthening the full path to payment, rather than optimizing one step while leaving the underlying cost elsewhere.

Faster detection only strengthens the return when it leads to quicker resolution, fewer downstream touches, and lower labor expense.

A practical revenue cycle AI review starts with First-Pass Performance. Measure whether more work is completed correctly before an edit, denial, appeal, rebill, or follow-up becomes necessary. The strategic objective is to turn AI into operating leverage, allowing the organization to handle greater revenue cycle complexity without adding cost.

‍

5. The 2030 portfolio can’t fund yesterday’s priorities. | 2030 Readiness Starts Now

‍Health system leaders can’t fund tomorrow’s priorities without making difficult decisions about today’s investments. 

A current investment shouldn’t be protected simply because it still performs its original function. CEOs and CFOs need to determine whether it improves financial performance across the enterprise. Leaders at the Exchange noted that the strongest investments connect enterprise revenue cycle data to action, reduce variation across facilities, and make reimbursement more predictable.

A 2030-ready portfolio requires executives to make two decisions with equal discipline: what to fund and what to stop funding. Continuing to protect investments that no longer strengthen cash flow, margin, or scalability limits the organization’s ability to execute higher-value priorities. 

‍

How Vee Healthtek turns priorities into executable results. | Vee Healthtek Supports Execution

‍Every priority competes for the same teams, so we start by showing which ones earn that capacity. We follow financial risk through the workflow to find where execution breaks down and rework begins. Practitioner-led analysis connects payer behavior with patient access, documentation, coding, claims, and A/R, so workflow changes target recurring causes. AI-enabled prioritization directs repeatable work to automation and complex exceptions to experienced teams, protecting reimbursement while preserving internal control.

A strong strategy begins with the workflow and ends with the financial result. Leaders who test investments for executability, remove lower-value initiatives, and measure First-Pass Performance will be most likely to protect current cash while building capabilities for the future. 

‍

Key Takeaways: | Key Takeaways

• Investment value depends on whether teams can execute change without weakening current cash performance.
• Portfolio review needs an explicit stop decision so lower-value work does not consume scarce capacity.
• Workforce capacity protects implementation quality and continuity across patient-to-payment workflows.
• AI earns its place when it moves risk to resolution and reduces rework, denials, or A/R aging.
• A 2030-ready portfolio connects enterprise priorities to first-pass yield and realized reimbursement.